Trial · NCT00661544
Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients
NCT00661544, Phase 1, Phase 2, Completed, M.D. Anderson Cancer Center; results first posted 2009-07-14
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients. Trials, record NCT00661544. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00661544
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients
- NCT number
- NCT00661544
- Status
- Completed
- Phases
- Phase 1, Phase 2
- Enrollment
- 48 participants, actual
- Lead sponsor
- M.D. Anderson Cancer Center
- Conditions
- Multiple Myeloma, Stem Cell Transplantation
- Interventions
- Arsenic Trioxide, Melphalan, Ascorbic Acid
- First posted
- 2008-04-18
- Last updated
- 2013-03-04
- Results first posted
- 2009-07-14
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Response Rate | 3, 6 and 12 months | Bone marrow aspirate and biopsy performed to assess complete response and overall response rate. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Response Rate | 3, 6 and 12 months | Participants | NUMBER |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Response Rate | Arsenic Trioxide + Vitamin C + Melphalan | Complete Response | 11 | Participants | |
| Response Rate | Arsenic Trioxide + Vitamin C + Melphalan | Overall Response (Complete + Partial Response) | 36 | Participants |
Source ClinicalTrials.gov
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Arsenic Trioxide + Vitamin C + Melphalan | 48 | |
| Overall Study | COMPLETED | Arsenic Trioxide + Vitamin C + Melphalan | 48 | |
| Overall Study | NOT COMPLETED | Arsenic Trioxide + Vitamin C + Melphalan | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Arsenic Trioxide + Vitamin C + Melphalan | ||
| Total, other adverse events | Arsenic Trioxide + Vitamin C + Melphalan | 0 | 48 |
| Total, serious adverse events | Arsenic Trioxide + Vitamin C + Melphalan | 0 | 48 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00661544
GET https://conductscience.org/api/trials/v1/NCT00661544/registered